Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to -$170000.0.

  • Ekso Bionics Holdings' Other Working Capital Changes rose 6892.14% to -$170000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$764000.0, marking a year-over-year decrease of 37285.71%. This contributed to the annual value of -$329000.0 for FY2024, which is 11651.61% down from last year.
  • Ekso Bionics Holdings' Other Working Capital Changes amounted to -$170000.0 in Q3 2025, which was up 6892.14% from -$406000.0 recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Other Working Capital Changes registered a high of $792000.0 during Q3 2023, and its lowest value of -$547000.0 during Q3 2024.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$36000.0 (2021), whereas its average is -$368.42.
  • In the last 5 years, Ekso Bionics Holdings' Other Working Capital Changes crashed by 38524.59% in 2021 and then soared by 159230.77% in 2023.
  • Over the past 5 years, Ekso Bionics Holdings' Other Working Capital Changes (Quarter) stood at -$36000.0 in 2021, then surged by 172.22% to $26000.0 in 2022, then surged by 1592.31% to $440000.0 in 2023, then tumbled by 138.41% to -$169000.0 in 2024, then dropped by 0.59% to -$170000.0 in 2025.
  • Its Other Working Capital Changes stands at -$170000.0 for Q3 2025, versus -$406000.0 for Q2 2025 and -$19000.0 for Q1 2025.